ClinicalTrials.gov record
Completed Phase 2 Interventional

Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard Chemotherapy

ClinicalTrials.gov ID: NCT00066846

Public ClinicalTrials.gov record NCT00066846. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 12:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter Study of the Anti-VEGF Monoclonal Antibody Bevacizumab (Avastin®) Plus 5-Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancers That Have Progressed After Standard Chemotherapy

Study identification

NCT ID
NCT00066846
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Cancer Institute (NCI)
NIH
Enrollment
Not listed

Conditions and interventions

Interventions

  • bevacizumab Biological
  • fluorouracil Drug
  • leucovorin calcium Drug

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2003
Primary completion
Not listed
Completion
Jun 30, 2007
Last update posted
Jun 19, 2013

2003 – 2007

United States locations

U.S. sites
33
U.S. states
26
U.S. cities
30
Facility City State ZIP Site status
Providence Alaska Medical Center Anchorage Alaska 99519-6604
Jonsson Comprehensive Cancer Center, UCLA Los Angeles California 90024
USC/Norris Comprehensive Cancer Center and Hospital Los Angeles California 90033-0804
University of Colorado Cancer Center at University of Colorado Health Sciences Center Aurora Colorado 80010
Yale Comprehensive Cancer Center New Haven Connecticut 06520-8028
Lombardi Cancer Center Washington D.C. District of Columbia 20007
CCOP - Atlanta Regional Atlanta Georgia 30342-1701
Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago Illinois 60611
Loyola University Medical Center Maywood Illinois 60153
Holden Comprehensive Cancer Center Iowa City Iowa 52242-1009
Siouxland Hematology-Oncology Sioux City Iowa 51101-1733
CCOP - Wichita Wichita Kansas 67214-3882
Cancer Care of Maine Bangor Maine 04401
Saint Joseph Mercy Health System Ann Arbor Michigan 48106
St. Mary's/Duluth Clinic Cancer Center Duluth Minnesota 55805
University of Mississippi Medical Center Jackson Mississippi 39216-4505
CCOP - Montana Cancer Consortium Billings Montana 59101
Southern Nevada Cancer Research Foundation Las Vegas Nevada 89106
Norris Cotton Cancer Center Lebanon New Hampshire 03756-0002
Roswell Park Cancer Institute Buffalo New York 14263-0001
New York Weill Cornell Cancer Center at Cornell University New York New York 10021
Duke Comprehensive Cancer Center Durham North Carolina 27710
Comprehensive Cancer Center at Wake Forest University Winston-Salem North Carolina 27157-1082
Meritcare Roger Maris Cancer Center Fargo North Dakota 58122
Ireland Cancer Center Cleveland Ohio 44106-5065
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104
Abramson Cancer Center of the University of Pennsylvania Philadelphia Pennsylvania 19104
Kimmel Cancer Center of Thomas Jefferson University - Philadelphia Philadelphia Pennsylvania 19107-5541
Sioux Valley Clinics - Oncology Sioux Falls South Dakota 57104
Fletcher Allen Health Care - University Health Center Campus Burlington Vermont 05401
Massey Cancer Center Richmond Virginia 23298-0037
CCOP - Virginia Mason Research Center Seattle Washington 98101
Seattle Cancer Care Alliance Seattle Washington 98109

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00066846, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 19, 2013 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00066846 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →